← Eichor
Condition: Runx1 Runx1T1 Fusion Protein Expression Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Runx1 Runx1T1 Fusion Protein Expression

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
Phase 3 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06744504
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.